Improving Technologies in Anesthesia by Kolbay, Patrick
1 
 
Improving Technologies in Anesthesia 
 
Patrick Kolbay, Joseph Orr, Kai Kück* 
University of Utah 
 
 
Abstract - General anesthesia is well known to 
offer physicians access to a broad variety of 
invasive procedures otherwise deemed too 
risky.  Anesthesia machines provides the means 
for anesthetizing patients safely in the hospital 
operating room.  However, these devices are 
increasingly unable to meet the demands and 
needs outside of the hospital.  Developing 
countries struggle to purchase and maintain 
these costly devices, leading to a 40-fold 
increase in anesthesia-related deaths compared 
to developed countries.  Small-office practices 
in the United States experience significantly 
poorer anesthesia outcomes and increased legal 
claims versus their larger hospital 
counterparts, resulting in 60% more 
anesthesia-related deaths.  Environmental 
impacts and global health concerns from the 
emitted anesthetic gases have brought into 
serious question the prevailing notion that 
unchecked emissions were sustainable.  These 
factors can all be attributed to anesthesia 
machine design and technology having the 
primary intended use in the traditional 
operating room.  The long-term goal of this 
work is to develop technologies in anesthesia 
that expand its safe use, decrease underlying 
costs, and reduce the total emissions.  The 
immediate objective of this work is to create a 
feedback-controlled anesthetic gas vaporizer-
scavenger system and evaluate its performance.  
The central hypothesis is that the combined use 
of mesoporous materials and feedback control 
provide the opportunity for repeatable capture 
and release of expired anesthetic gases during 
anesthesia delivery.  Our rationale is that such 
a device will help reduce the amount of 
anesthetic needed while simultaneously offering 
improved control over the delivery of anesthetic 
gases.   
I. INTRODUCTION 
 
Anesthesia machines and systems are at the center 
of surgical care and provide support for 
anesthesiologists to administer anesthesia. Several 
technological advances have led to a drastic 
improvement in anesthesia safety in the hospital, 
transforming it from one of the most dangerous 
aspects of surgery to one of the safest. 1–5 
However, outside of the traditional hospital 
operating room, many diverse problems still exist 
in anesthesia. 
 
Global Access to Anesthesia 
There are 5 billion people globally that still have 
inadequate access to anesthetic care, primarily in 
South Asia and Sub-Saharan Africa.6  Hospitals in 
austere conditions that have been able to provide 
anesthetic care have been unable to match the 
reduction in anesthesia-related morbidity and 
mortality seen in the developed world.7,8 This 
discrepancy stems from a combined lack of 
clinical staff, equipment, space, and systems of 
surgical care delivery.9,10  Significant efforts have 
been made to increase access to clinical staff, 
primarily through increases in local education 
programs as well as humanitarian efforts through 
programs like  Médecins Sans Frontières (MSF, 
also known as Doctors Without Borders).11–14  
Deficits in technical resources and equipment 
remain an unsolved problem none the less.  Lack 
of healthcare resources and infrastructure has led 
many developing countries to import equipment 
despite it being ill-suited for the environment.  
Much of this healthcare equipment is being funded 
by both international donors and foreign 
governments, with donations comprising nearly 
80% of the incoming anesthesia equipment for 
some developing countries.15 Despite these 
donations, the expertise and parts required to 
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maintain them leads to as little as 10% of these 
donated machines ever becoming operational.9,16 
Rudimentary anesthesia machines have been 
developed in an effort to overcome this issue by 
incorporating uninterruptible power supplies, 
oxygen concentrators, and simple draw over 
vaporizers.17,18  While certainly beneficial, these 
anesthesia machines still fail to provide any access 
to patient monitoring, the primary method by 
which clinicians prevent anesthesia-related 
morbidity and mortality in the developed world.19  
Additionally these devices do nothing to address 
the need of anesthetic scavenging systems in 
resource-limited settings.11  Ultimately, this 
resource gap contributes to a scarcity of operating 
facilities in low resource areas, with the estimated 
number of operating rooms being more than 25 
times less than high-income regions, culminating 
in a 40 fold increase in anesthesia-related death.8,9 
 
Increases in U.S. Anesthesia Complications 
The economics and demands of healthcare in the 
United States are pushing anesthesia from in-
hospital to outpatient and small-office settings, 
raising concerns over quality of care and patient 
safety.20  Initial lack in mandatory accreditation of 
small office anesthesia practices may have 
contributed to a marked increase in adverse events 
in anesthesia.  An ASA Closed Claims analysis 
showed that for small office claims, more than 
40% of monitored anesthesia care (MAC) claims 
involved permanent brain damage and 21% of 
MAC claims had unaddressed respiratory 
depression, half of which were deemed 
preventable by better patient monitoring.21  While 
new mandatory accreditation and stricter state 
regulation have improved these outcomes in small-
office practice, there still remains a discrepancy in 
the standard of care compared to hospitals.22,23  
The capital cost, space requirements, and necessity 
for scavenging systems in anesthesia machines 
cause many clinicians to turn to total intravenous 
anesthetics (TIVA) without the safety net of 
ventilation equipment or monitoring, a primary 
contributing factor of these negative outcomes.24  
Due to their higher fat solubility, intravenous 
anesthetics often result in drug accumulation and 
then subsequent delays in recovery once infusion 
has stopped.25  More importantly, the inability 
measure drug concentration, and therefore 
anesthetic depth, is the most pronounced reason 
for avoiding intravenous anesthetics.  As a result, 
titrating a dose correctly requires an experienced 
clinician to account for patient variability, 
nonlinear relationships between dose and effect, 
and the synergistic effects between drugs.    In a 
study of 90 patients receiving either propofol (an 
intravenous anesthetic), isoflurane, or desflurane 
(both inhalational anesthetics) for anesthesia 
maintenance, the percentage of patients with 
purposeful movement was 63% for those who 
received propofol, and only 23% and 6.7% for 
those receiving isoflurane and desflurane 
respectively.26  Attempts have been made to 
monitor the effects of intravenous anesthetics on 
the brain using the Bispectral Index (BIS), 
however there exists widespread controversy on its 
consistency in determining patient awareness.38  
In contrast, inhalational anesthesia is set by 
alveolar concentration, which has a far more 
robust and established relationship to effect.27   
Inhalational anesthesia has also shown to be 
preferable for induction and maintenance in 
pediatric cases, as children often have a fear of 
needles, and inhalational induction is painless and 
entirely noninvasive.28  Finally, because 
inhalational anesthesia is delivered by 
concentration and not dose, the maximum 
concentration in the body is capped, decreasing the 
likelihood of overdose. 
 
Environmental Impacts of Anesthesia 
Alongside the need for patient monitoring, the 
ability to safely scavenge expired anesthetic gases 
from the anesthesia machine and away from 
clinicians remains another hurdle outside of the 
hospital.11,29–31  This hurdle encourages the use of 
TIVA over inhalational anesthetics at both 
increased financial cost and risk of undetected 
respiratory depression.24  Even with appropriate 
anesthetic scavenging or respiratory monitoring, a 
secondary impact of inhalational anesthetics is the 
negative environmental impact.32  Anesthetic 
gases have a global warming potential more than 
3700 times that of carbon dioxide and contribute 
to over 1% of the global ozone depletion despite 
the relatively small size of anesthesia 
emisisons.33,34  The introduction of semi-closed 
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anesthesia rebreathing circuits and low fresh gas 
flow techniques have reduced anesthetic waste, but 
these still require scavenging systems and 
additionally necessitate carbon dioxide 
scrubbing.35,36  This environmental impact could 
be dismissed in the face of immediate patient 
health.  However, it is estimated the damages 
generated by health-care industry pollutants well 
exceed the 44,000-98,000 who die annual due to 
preventable medical errors.37,38  In anesthesia, 
volatile agent release marks the primary 
environmental burden (Figure 3.1-1).39,40  
A system that “reflects” anesthetics back to the 
patient would remove the need for a scavenging 
and carbon dioxide removal while also 
significantly reducing the environmental impact of 
anesthesia by reintroducing open non-rebreathing 
circuits.  Removing carbon dioxide scrubbing has 
additional benefits beyond costs and complex 
logistics.  The absorbents used can cause inhaled 
anesthetics to degrade into carbon monoxide, 
particularly during low fresh gas flow and when 
the absorbent is desiccated, with concentrations 
being lethal in porcine experiments and posing 
significant risks to pediatric patients.41,42  Open 
breathing circuits additionally reduce the 
technological barriers to using volatile anesthetics 
in tandem with sophisticated ICU ventilators, 
potentially allowing for the use of volatile agents 
in long-term sedation in the ICU.  Porous 
materials, such as activated charcoal, have been 
shown effective in capturing anesthetics.43  Once 
saturated, however, the adsorption and release of 
anesthetic gas could occur rapidly, allowing for 
capture during exhalation and reflection at 
inhalation, while simultaneously allowing carbon 
dioxide, oxygen, and nitrogen to pass freely.  This 
research focuses of a variety of technological 
advances in anesthesia delivery to address these 
issues. 
Figure 3.1-1 Total life cycle environmental impacts of an average hysterectomy by surgery type (normalized to highest hysterectomy type 
in impact category). Negative values reflect positive environmental impacts due to recycling; Error bars represent 90% confidence interval 
from Monte Carlo Analysis.11 
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Improving Monitoring in Anesthesia 
Current methods of measuring anesthetic gas 
concentrations rely on the unique infrared 
absorption profile of each anesthetic gas.  
Determining the concentration therefore requires a 
variety of infrared filters to identify specifics 
absorptions peaks, followed by measuring the 
concentration via the Lambert-Beer Law.  While 
effective, infrared spectroscopy is cost-intensive 
due to the optics required to continuously measure 
the adsorption of various infrared wavelengths.  
However, using differences in gas density using 
orifice-plate flow sensors poses an alternative 
method for measuring gas concentrations in binary 
mixtures. Orifice-plate flow sensors traditionally 
determine fluid velocity utilizing Bernoulli’s Law 
(Figure 3.2-1). Given a known fluid velocity, they 
can instead be used to determine fluid density. By 
combining an orifice-plate sensor with an 
additional fluid velocity sensor independent to 
changes in density, the total fluid velocity and 
composition can be determined.  This concept has 
been proven feasible for measuring various 
mixtures of helium, carbon dioxide, argon, and 
room air.44–46 However, no one has yet developed 
an anesthetic gas sensor using this technique.  The 
difference in density between anesthetic gas and 
room air nearly matches the difference between 
room air and helium (5 times and 6.8 times greater 
respectively).  The accuracy of these devices is 
also much higher than infrared spectroscopy, with 
the percent error for such a device being between 
±7.5% by volume compared to ±16.7% by volume 
for infrared spectroscopy.44,47 
Characterizing Mass Transfer of Anesthetics in 
Porous Materials 
Our key innovation is developing a new method 
for reusing expired anesthetic gases through 
continuous, reversible sorption via mesoporous 
materials.  Mesoporous materials have long been 
used for capturing volatile organic compounds, in 
some cases reversibly.48  Utilizing mesoporous 
materials to reflect anesthetic gases is not an 
entirely novel idea, however it is poorly explored 
and understood.49  The broad spectrum of pore 
sizes in activated charcoal has made it the material 
of choice for feasibility testing.  However, other 
materials have remained untested in their ability to 
specifically capture and release anesthetic gases.  
We have previously measured the rate of release of 
release of isoflurane from activated charcoal.50  In 
a similar way, we are investigating the effects of 
pore size, material affinity, flow rate, and 
gas/adsorbed phase concentration on the sorption 
isotherm with isoflurane, sevoflurane, and 
desflurane.  
 
Feedback Control of Capture and Release of 
Anesthetic Gases 
Reflecting anesthetic gas back to the patient 
through the means of a porous medium would 
represent a unique method for volatile anesthetic 
agent recovery and delivery.  If this method of 
anesthetic delivery is successful, it would allow for 
anesthesia breathing circuits that remove 
scavenging systems, carbon dioxide scrubbers, and 
significantly reduce the amount of anesthetic used 
and wasted during anesthetic maintenance.  
Previously explored was incorporating such a 
device into the rebreathing circuit of an anesthesia 
machine.  Such a device was able to show that over 
the course of a 2 hour mock surgery, activated 
charcoal is capable of reducing the anesthetic gas 
needed by over 90% and anesthetic concentrations 
were maintained to a given set point.50,51  Future 
iterations depend largely on the material 
capabilities found in ongoing research, with this 
system being feasibly incorporated at various 
stages in the anesthesia breathing circuit, each with 
distinct advantages and disadvantages such as 
range of flow rates and synchrony with patient 
ventilation.  In addition, incorporating feedback 
control into this device will enable a higher level 
Figure 3.2-1 Cutaway of an orifice plate flow meter.  As gas flows 
through the orifice, it generates a pressure difference described by 
Bernoulli’s Law. Alternatively, the phenomenon can instead by 
used to determine fluid density. 
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of efficiency in anesthetic gas delivery and 
recovery. The basic principle of feedback control 
consists of measuring the difference between the 
feedback signal (anesthetic gas concentration) and 
the desired set point.  A controller utilizes 
algorithms to then produce a related output that 
reduces this difference.  The related output is 
converted to changes in an actuator (variable flow 
bypass, temperature, pressure, etc.) to illicit a 
physical change in concentration that better 
matches the set point.  Feedback control systems, 
when implemented corrected, allow for more 
stable, accurate, and fast systems.  Ultimately, a 
device that results in a faster step response then has 
additional applications in patient-included closed-
loop feedback control using pharmacokinetics and 
pharmacodynamics, target-controlled anesthesia, 
time course delivery, etc.52–54  These closed-loop 
autonomous systems have been shown to result in 
better control over the delivery of anesthesia with 
significant reduction in dose overshooting and 
undershooting.55 
 
II.  METHODS 
 
Sensor Fusion for Anesthetic Concentration 
Sensing 
A custom anesthesia machine was created, 
consisting of a fresh oxygen inlet, anesthetic 
vaporizer, charcoal scavenging outlet, and custom 
rebreathing circuit.  The custom rebreathing circuit 
consisted of a radial turbine with fluid resistor and 
differential pressure sensor anteriorly.  The fluid 
resistor enabled flow changes from the radial 
turbine to yield pressure changes in that leg of the 
circuit, allowing for the ventilation of a 
mechanical lung simulator (TTL Michigan 
Testlung, Michigan Instruments, Grand Rapids, 
MI).  Finally, posterior to the radial turbine was a 
reservoir bag (Figure 2.1-1).  Data was collected 
from the radial turbine tachometer and differential 
pressure sensor, both serving as indicators of gas 
flow.  Several tests were performed to characterize 
the behavior of these sensors in various conditions.  
This included steady state flow tests ranging from 
2-60 liters per minute to calibrate both sensors 
using a standard gas flow bench (VT-Plus Gas 
Flow Analyzer, Fluke Corp., Everett, WA), 
cyclical tests to determine and correct for 
hysteresis between the tachometer and the 
differential pressure sensor, and verification tests 
to ensure the tachometer’s independence in 
measured flow with the presence of isoflurane.  
Once a baseline with no anesthetic gas had been 
determined, the radial turbine was set to ventilate 
a test lung at 12 breaths per minute, with a tidal 
volume of 500 milliliters.  Isoflurane was then 
introduced into the system at concentrations 
ranging from 0-3.0%, which was measured using 
a standard infrared gas bench (Datex-Ohmeda, 
Helsinki, Finland).   The difference in flow 
measured by the differential pressure sensor from 
the turbine tachometer was attributed to changes in 
the gas density, and therefore isoflurane 
concentration.  This difference was then passed 
through a simple alpha-beta filter and used to 
estimate the isoflurane concentration.  This result 
was then compared to the infrared gas bench.  All 
sensors were sampled at 20 Hz. 
 
Sorption Isotherm of Porous Materials with 
Anesthetic gases 
Two generalized tests were performed to better 
understand the general behavior of activated 
charcoal and anesthetic gases.  The first test 
consisted of a 5 L/min flow of oxygen containing 
5% isoflurane (Piramal Healthcare Limited, 
Andhra Pradesh, India) to be passed through a 
cylindrical vessel containing 42 grams of activated 
charcoal (Oxpure 1220C-75, Oxbow Activated 
Carbon, West Palm Beach, FL) until 0.5% 
Figure 2.1-1 A radial blower (1) passes air through a variable 
valve (2) which can be actuated to scavenge anesthetic from the 
circuit through a filter (3).  A differential pressure flow sensor 
measures changes in flow and density (4), while a test lung (5) is 
ventilated by changes in pressure caused by changed in flow from 
the blower and a fluid resistor (6).  Isoflurane can be injected into 
the system using a custom vaporizer (7) and a reservoir bag (8) 
adds extra volume to ventilate the test lung. 
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isoflurane pushed through (approximately 10 
minutes).  The vessel was sealed and weighed to 
determine the amount of anesthetic gas adsorbed 
onto the surface of the charcoal.  Next, a gas flow 
containing pure oxygen was pushed through the 
vessel at a rate of 2 L/min and the concentration of 
anesthetic gas leaving the vessel was measured.  
The same process was repeated with non-porous 
beads as a control. A second test consisted of a 
smaller vessel containing 10 grams of partially-
saturated activated charcoal (total weight of 14 
grams) placed between the Y-piece of an 
anesthesia circuit and a mechanical lung simulator 
(TTL Michigan Testlung, Michigan Instruments, 
Grand Rapids, MI).  This test lung was then driven 
using a ventilator and 100% oxygen, with the 
concentration of isoflurane between the vessel and 
test lung being monitored.  A control was 
performed with non-porous beads. 
 
Anesthetic Gas Scavenger-Vaporizing Device 
Test 
An initial proof-of-concept prototype was 
demonstrated and fitted within the rebreathing 
circuit of a current anesthesia.  This system 
consisted of a housing with two chambers, one 
fitted with a charcoal cartridge, and the other open 
to free gas flow.  A gear with a semicircular 
opening was actuated externally to determine 
which chamber, or combination of chambers, had 
fresh gas traveling through from the anesthesia 
machine to the simulated lung.  In addition, 
differential pressure sensors were attached at both 
chambers to detect inhalation and exhalation.  
Anesthetic gas concentration measurements from 
a standard infrared gas bench was used for basic 
feedback control.  A microcontroller controlled the 
orientation of the gear valve to titrate the 
anesthetic concentration based on breath detection, 
anesthetic gas concentration, and a user input for 
desired anesthetic concentration using a 
rudimentary hysteresis controller. 
 
III.  RESULTS 
 
A. Anesthetic Concentration Sensing 
The mean difference in measured isoflurane 
concentration to estimated isoflurane 
concentration was -0.025% volume, with a 
standard deviation of 0.091% volume.  In a total of 
over 26,000 measurements, 95% of the estimated 
isoflurane concentrations fell within 0.2% volume 
of the measured isoflurane concentration, which is 
within the accuracy limitations of the infrared gas 
bench itself (Figure 3.1-1).  No statistically 
significant difference was found in estimating the 
isoflurane concentration in pure oxygen versus 
room air.  
B. Sorption Isotherm of Porous Materials 
Isoflurane was released at concentrations suitable 
for anesthesia maintenance for a significant 
amount of time, approximately 10 minutes (Figure 
3.2-1).  Ventilation was also tested to investigate 
more dynamic conditions where the device was 
ventilated with a test lung (Figure 3.2-2).  Once 
saturated, the activated charcoal had absorbed 
approximately 60% of its total weight in isoflurane 
and was capable of repeatedly reflecting 10% of its 
total weight in isoflurane or about 3.2 mL of liquid 
isoflurane.  This volume of isoflurane capable of 
being reflected is the equivalent of anesthesia 
maintenance at 1 MAC for 1 hour at a fresh gas 
flow rate of 1 liter per minute. 
 
Figure 3.1-1 Plot of the measured anesthetic concentration versus 
the estimated anesthetic concentrations (top) along with a Bland-
Altman analysis of the two sensors against each other (bottom). 
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C. Prototype Device Design 
A prototype was successfully created and was 
capable of performing the basic desired functions.  
Specifically, inspiratory and expiratory flows were 
detected and a basic “bang-bang” feedback control 
was implemented to achieve the desired 
concentration. Once the charcoal had been 
saturated from a mock anesthesia induction, the 
controller was able to maintain average isoflurane 
concentrations within 0.2% by volume of the user 
set point (1.2% by volume). 
 
IV.  DISCUSSION 
 
Activated carbon has been shown to readily 
absorb and release anesthetic gases. Creating a 
system using this material would allow for the 
implementation of an activated carbon reflector 
that absorbs, holds, and releases anesthetic gases 
back to the patient. Not only would this remove 
the need for an anesthetic scavenging system, but 
it would also significantly decrease the cost of 
anesthetic maintenance by reducing the amount 
of gas vaporized. Preliminary data has shown that 
40-mesh activated carbon can capture anesthetic 
gases and release them with reversed flow at a 
concentration high enough for sedation. By 
combining this material with a novel breathing 
circuit design, we will remove the need for a 
scavenging system and expand the environments 
in which anesthesia can be used.   Success in this 
research will ultimately reduce the cost, 
infrastructure, and expertise needed to deliver 
general anesthesia. By doing this, the global 
access to anesthesia and surgical will be greatly 
increased, reducing the suffering in the world. 
 
Future work will include further development and 
tuning of this technology and incorporating it 
with other advances in the field of anesthesiology 
to create a novel anesthesia machine that 
addresses the needs in both the developing world 
and the emerging small-office anesthesia.  These 
will include better patient monitoring, reduced 
machine footprint, and patient-included feedback 
control. 
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